![Eva-Lotta Allan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 39 750 $ al 31/07/2026
Ms. Eva-Lotta Allan is a Non-Executive Chairman at Maxion Therapeutics Ltd., a Non-Executive Chairman at Draupnir Bio ApS and an Independent Non-Executive Director at Almirall SA. She is on the Board of Directors at Zelluna ASA, Almirall SA and Zelluna Immunotherapy AS.
Ms. Allan was previously employed as a Non-Executive Director by Aleta Biotherapeutics, Inc., a Non-Executive Chairman by C4X Discovery Holdings Ltd., a Non-Executive Director by Crescendo Biologics Ltd., an Independent Director by Targovax ASA, a Director & Chief Business Officer by Immunocore Holdings Ltd., a Chief Business Officer by Ablynx NV, a Senior Director-Global Business Development by Vertex Pharmaceuticals (Europe) Ltd., a Principal by GE Healthcare Ltd. (United Kingdom), a Principal by Karolinska Institutet, a Principal by Oxford Asymmetry International Plc, and a Principal by Oxford GlycoSciences Plc.
She also served on the board at Novavax AB and The Bioindustry Association.
She received her undergraduate degree from the University of Stockholm.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,06 % | 31/12/2025 | 16.250 ( 0,06 % ) | 39 750 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALMIRALL, S.A. | Director/Miembro de la Junta | 01/07/2020 |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Presidente | 21/09/2023 |
Draupnir Bio ApS
 Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Presidente | 01/06/2021 |
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Director/Miembro de la Junta | 01/11/2024 |
| C4X DISCOVERY HOLDINGS PLC | Presidente | 20/06/2023 |
| CIRCIO HOLDING ASA | Director/Miembro de la Junta | 01/05/2023 |
| IMMUNOCORE HOLDINGS PLC | Director/Miembro de la Junta | 01/04/2018 |
| ABLYNX | Public Communications Contact | 04/05/2010 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 18 |
|---|---|
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells vaccine adjuvants | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
C4X Discovery Holdings Plc
 C4X Discovery Holdings Plc Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Health Technology |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Commercial Services |
Draupnir Bio ApS
Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
